Novel genetic and epigenetic alterations in ... - Ous-research.no
Share Embed Flag
Download ePaper

Novel genetic and epigenetic alterations in ... - Ous-research.no

Novel genetic and epigenetic alterations in ... - Ous-research.no Novel genetic and epigenetic alterations in ... - Ous-research.no

ous.research.no
from ous.research.no More from this publisher
11.07.2015 Views

References156. Meling GI, Lothe RA, Børresen AL, Hauge S, Graue C, Clausen OP, Rognum TO(1991) Genetic alterations within the retinoblastoma locus in colorectalcarcinomas. Relation to DNA ploidy pattern studied by flow cytometricanalysis. Br J Cancer 64(3): 475-480157. Berg KD, Glaser CL, Thompson RE, Hamilton SR, Griffin CA, Eshleman JR (2000)Detection of microsatellite instability by fluorescence multiplex polymerasechain reaction. J Mol Diagn 2(1): 20-28158. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G (2002)Relative quantification of 40 nucleic acid sequences by multiplex ligationdependentprobe amplification. Nucleic Acids Res 30(12): e57159. Den Dunnen JT, White SJ (2006) MLPA and MAPH: sensitive detection ofdeletions and duplications. Curr Protoc Hum Genet Chapter 7:Unit 7.14.160. Vorstman JA, Jalali GR, Rappaport EF, Hacker AM, Scott C, Emanuel BS (2006)MLPA: a rapid, reliable, and sensitive method for detection and analysis ofabnormalities of 22q. Hum Mutat 27(8): 814-821161. Hogervorst FB, Nederlof PM, Gille JJ, McElgunn CJ, Grippeling M, Pruntel R,Regnerus R, van WT, van SR, Menko FH, Kluijt I, Dommering C, Verhoef S,Schouten JP, van't Veer LJ, Pals G (2003) Large genomic deletions andduplications in the BRCA1 gene identified by a novel quantitative method.Cancer Res 63(7): 1449-1453162. Schwartz M, Duno M (2005) Multiplex ligation-dependent probe amplificationis superior for detecting deletions/duplications in Duchenne musculardystrophy. Clin Genet 67(2): 189-191163. Chan AO, Broaddus RR, Houlihan PS, Issa JP, Hamilton SR, Rashid A (2002) CpGisland methylation in aberrant crypt foci of the colorectum. Am J Pathol 160(5):1823-1830164. Loganayagam A (2008) Faecal screening of colorectal cancer. Int J Clin Pract62(3): 454-459165. Zou H, Taylor WR, Harrington JJ, Hussain FT, Cao X, Loprinzi CL, Levine TR, RexDK, Ahnen D, Knigge KL, Lance P, Jiang X, Smith DI, Ahlquist DA (2008) HighDetection Rates of Colorectal Neoplasia by Stool DNA Testing With a NovelDigital Melt Curve Assay. Gastroenterology166. Syngal S, Stoffel E, Chung D, Willett C, Schoetz D, Schroy P, Jagadeesh D, Morel K,Ross M (2006) Detection of stool DNA mutations before and after treatment ofcolorectal neoplasia. Cancer 106(2): 277-283167. Koga Y, Yasunaga M, Moriya Y, Akasu T, Fujita S, Yamamoto S, Kozu T, Baba H,Matsumura Y (2008) Detection of colorectal cancer cells from feces using80

Referencesquantitative real-time RT-PCR for colorectal cancer diagnosis. Cancer Sci99(10): 1977-1983168. Muller HM, Oberwalder M, Fiegl H, Morandell M, Goebel G, Zitt M, Muhlthaler M,Ofner D, Margreiter R, Widschwendter M (2004) Methylation changes in faecalDNA: a marker for colorectal cancer screening? Lancet 363(9417): 1283-1285169. Chen WD, Han ZJ, Skoletsky J, Olson J, Sah J, Myeroff L, Platzer P, Lu S, DawsonD, Willis J, Pretlow TP, Lutterbaugh J, Kasturi L, Willson JK, Rao JS, Shuber A,Markowitz SD (2005) Detection in fecal DNA of colon cancer-specificmethylation of the nonexpressed vimentin gene. J Natl Cancer Inst 97(15): 1124-1132170. Lofton-Day C, Model F, Devos T, Tetzner R, Distler J, Schuster M, Song X, LescheR, Liebenberg V, Ebert M, Molnar B, Grutzmann R, Pilarsky C, Sledziewski A(2008) DNA methylation biomarkers for blood-based colorectal cancerscreening. Clin Chem 54(2): 414-423171. Itzkowitz SH, Jandorf L, Brand R, Rabeneck L, Schroy PC, III, Sontag S, JohnsonD, Skoletsky J, Durkee K, Markowitz S, Shuber A (2007) Improved fecal DNA testfor colorectal cancer screening. Clin Gastroenterol Hepatol 5(1): 111-117172. Oberwalder M, Zitt M, Wontner C, Fiegl H, Goebel G, Zitt M, Kohle O, MuhlmannG, Ofner D, Margreiter R, Muller HM (2008) SFRP2 methylation in fecal DNA--amarker for colorectal polyps. Int J Colorectal Dis 23(1): 15-19173. Wang DR, Tang D (2008) Hypermethylated SFRP2 gene in fecal DNA is a highpotential biomarker for colorectal cancer noninvasive screening. World JGastroenterol 14(4): 524-531174. Huang Z, Li L, Wang J (2007) Hypermethylation of SFRP2 as a potential markerfor stool-based detection of colorectal cancer and precancerous lesions. DigDis Sci 52(9): 2287-2291175. Tan SH, Ida H, Lau QC, Goh BC, Chieng WS, Loh M, Ito Y (2007) Detection ofpromoter hypermethylation in serum samples of cancer patients bymethylation-specific polymerase chain reaction for tumour suppressor genesincluding RUNX3. Oncol Rep 18(5): 1225-1230176. Nakayama G, Hibi K, Nakayama H, Kodera Y, Ito K, Akiyama S, Nakao A (2007) Ahighly sensitive method for the detection of p16 methylation in the serum ofcolorectal cancer patients. Anticancer Res 27(3B): 1459-1463177. Leung WK, To KF, Man EP, Chan MW, Bai AH, Hui AJ, Chan FK, Sung JJ (2005)Quantitative detection of promoter hypermethylation in multiple genes in theserum of patients with colorectal cancer. Am J Gastroenterol 100(10): 2274-2279178. Grutzmann R, Molnar B, Pilarsky C, Habermann JK, Schlag PM, Saeger HD,Miehlke S, Stolz T, Model F, Roblick UJ, Bruch HP, Koch R, Liebenberg V, Devos81

Referencesquantitative real-time RT-PCR for colorectal cancer diag<strong>no</strong>sis. Cancer Sci99(10): 1977-1983168. Muller HM, Oberwalder M, Fiegl H, Mor<strong>and</strong>ell M, Goebel G, Zitt M, Muhlthaler M,Ofner D, Margreiter R, Widschwendter M (2004) Methylation changes <strong>in</strong> faecalDNA: a marker for colorectal cancer screen<strong>in</strong>g? Lancet 363(9417): 1283-1285169. Chen WD, Han ZJ, Skoletsky J, Olson J, Sah J, Myeroff L, Platzer P, Lu S, DawsonD, Willis J, Pretlow TP, Lutterbaugh J, Kasturi L, Willson JK, Rao JS, Shuber A,Markowitz SD (2005) Detection <strong>in</strong> fecal DNA of colon cancer-specificmethylation of the <strong>no</strong>nexpressed viment<strong>in</strong> gene. J Natl Cancer Inst 97(15): 1124-1132170. Lofton-Day C, Model F, Devos T, Tetzner R, Distler J, Schuster M, Song X, LescheR, Liebenberg V, Ebert M, Molnar B, Grutzmann R, Pilarsky C, Sledziewski A(2008) DNA methylation biomarkers for blood-based colorectal cancerscreen<strong>in</strong>g. Cl<strong>in</strong> Chem 54(2): 414-423171. Itzkowitz SH, J<strong>and</strong>orf L, Br<strong>and</strong> R, Rabeneck L, Schroy PC, III, Sontag S, JohnsonD, Skoletsky J, Durkee K, Markowitz S, Shuber A (2007) Improved fecal DNA testfor colorectal cancer screen<strong>in</strong>g. Cl<strong>in</strong> Gastroenterol Hepatol 5(1): 111-117172. Oberwalder M, Zitt M, Wontner C, Fiegl H, Goebel G, Zitt M, Kohle O, MuhlmannG, Ofner D, Margreiter R, Muller HM (2008) SFRP2 methylation <strong>in</strong> fecal DNA--amarker for colorectal polyps. Int J Colorectal Dis 23(1): 15-19173. Wang DR, Tang D (2008) Hypermethylated SFRP2 gene <strong>in</strong> fecal DNA is a highpotential biomarker for colorectal cancer <strong>no</strong>n<strong>in</strong>vasive screen<strong>in</strong>g. World JGastroenterol 14(4): 524-531174. Huang Z, Li L, Wang J (2007) Hypermethylation of SFRP2 as a potential markerfor stool-based detection of colorectal cancer <strong>and</strong> precancerous lesions. DigDis Sci 52(9): 2287-2291175. Tan SH, Ida H, Lau QC, Goh BC, Chieng WS, Loh M, Ito Y (2007) Detection ofpromoter hypermethylation <strong>in</strong> serum samples of cancer patients bymethylation-specific polymerase cha<strong>in</strong> reaction for tumour suppressor genes<strong>in</strong>clud<strong>in</strong>g RUNX3. Oncol Rep 18(5): 1225-1230176. Nakayama G, Hibi K, Nakayama H, Kodera Y, Ito K, Akiyama S, Nakao A (2007) Ahighly sensitive method for the detection of p16 methylation <strong>in</strong> the serum ofcolorectal cancer patients. Anticancer Res 27(3B): 1459-1463177. Leung WK, To KF, Man EP, Chan MW, Bai AH, Hui AJ, Chan FK, Sung JJ (2005)Quantitative detection of promoter hypermethylation <strong>in</strong> multiple genes <strong>in</strong> theserum of patients with colorectal cancer. Am J Gastroenterol 100(10): 2274-2279178. Grutzmann R, Molnar B, Pilarsky C, Habermann JK, Schlag PM, Saeger HD,Miehlke S, Stolz T, Model F, Roblick UJ, Bruch HP, Koch R, Liebenberg V, Devos81

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!